Table 1 Shows demographic characteristics and hemodynamic data of both groups. Continuous data represented as mean and standard deviation (SD), and categorical data as number and percentage (%).
Parameter | Sch-PAH (n = 41) | IPAH (n = 42) | P | ||||
|---|---|---|---|---|---|---|---|
Age (years) Gender Female | Mean/N | SD/% | Mean/N | SD/% | < 0.001 † | ||
50.4 | 12 | 34.45 | 9.71 | ||||
13 | 31.71 | 36 | 85.71 | < 0.001 * | |||
Male Presence of comorbidity | 28 | 68.29 | 6 | 14.29 | |||
11 | 26.83 | 1 | 2.38 | 0.002* | |||
Diabetes mellitus | 2 | 4.88 | 0 | 0 | 0.24* | ||
Cardiovascular disease | 3 | 7.32 | 1 | 2.38 | 0.35* | ||
Chest disease | 3 | 7.32 | 0 | 0 | 0.03* | ||
Hepatic disease (1 HBV, 2HCV, 2HCC) WHO FC FC-I | 5 | 12.2 | 0 | 0 | 0.02 * | ||
2 | 4.88 | 3 | 7.14 | 0.66* | |||
FC-II | 16 39.02 | 20 47.62 | 0.42* | ||||
FC-III | 18 | 43.9 | 19 | 45.24 | 0.91* | ||
FC-IV 6MWD (meters) Echocardiography PASP (mmHg) | 5 | 12.2 | 0 | 0 | 0.007* | ||
296.4 | 82.2 | 300.5 | 96 | 0.83 † | |||
85.1 | 24.2 | 85.1 | 24.2 | 0.41† | |||
Dilated RA | 39 | 95.12 | 37 | 88.1 | 0.24* | ||
Dilated RV | 39 | 95.12 | 39 | 92.86 | 0.66* | ||
Dilated LA | 18 | 43.9 | 7 | 16.67 | 0.006* | ||
Pericardial effusion | 4 | 9.76 | 6 | 14.29 | 0.52* | ||
EF (%) Hemodynamic mRAP | 66.5 | 6.13 | 68.11 | 7.94 | 0.35 † | ||
9.87 | 5.98 | 9.85 | 5.34 | 0.98† | |||
mPAP | 54.9 | 11.8 | 56.9 | 16 | 0.55† | ||
CI | 2.52 | 1.06 | 2.56 | 1.08 | 0.86† | ||
PVR | 11.91 | 6.01 | 15 | 12.7 | 0.18† | ||
Svo2 | 60.69 | 8.74 | 62.6 | 11.2 | 0.41† | ||
PA dilatation (by Chest CT > 32 mm) Duration of illness in month (from the beginning of symptoms till time of diagnosis) Outcome Alive All-cause mortality Mono-Therapy | 6 | 14.63 | 0 | 0 | 0.01* | ||
35.4 | 14.6 | 28.7 | 14.9 | 0.04† | |||
34 7 5 | 82.93 17.07 12.2 | 37 5 1 | 88.1 11.9 2.38 | 0.51 0.08* | |||